Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0331 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-008 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0275 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8509 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-78 |
filingDate |
2002-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1832b3b22a01c50b5909b5cc7d2388b3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9799dafa85ac3eacdacdeb67ede36b7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1993364d01a0ea487c6ce4ebbb2bd9c7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff2d1e7d218376355fb3eea99d29a03c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_387faa848698eea456a455bae41ac69f |
publicationDate |
2004-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2004250303-A1 |
titleOfInvention |
Animal model exhibiting cancer, pulmonary emphysema and cardiomyopathy |
abstract |
The present invention relates to an animal model and cells which do not produce functional latent transforming growth factor β binding protein 4 or which produce suboptimal levels of latent transforming growth factor β binding protein 4. Furthermore, the present invention relates to mehods and kits for diagnosing cancer, pulmonary emphysema or cardiomyopathy and analyzing whether cancer and/or pulmonary emphysema and/or cardiomyopathy are caused by a differential expression of LTBP-4 or by a defect in LTBP-4 gene. Moreover the present invention relates to selecting an agent for treating a sympton occurring in the animal model of the invention. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9074175-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012196282-A1 |
priorityDate |
2001-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |